SP358THE COST-EFFECTIVENESS OF CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR ONCE MONTHLY VERSUS EPOETIN THRICE WEEKLY FOR ANAEMIA MANAGEMENT IN CHRONIC HAEMODIALYSIS PATIENTS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.